Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000747

Drug Information
NameCethrin
CompanyAlseres Pharmaceuticals Purchased rights for Cethrin from BioAxone Therapeutic, Inc.
IndicationSpinal cord injury
[ICD9: 952   ICD10: S14, S24, S34]
Phase I/IIa completed    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C23H30ClN3O.2ClH/c1-5-27(6-2)11-7-8-16(3)25-22-14-18(24)15-23-
20(22)13-17-12-19(28-4)9-10-21(17)26-23;;/h9-10,12-16,25H,5-8,11H
2,1-4H3;2*1H
InChIKeyQKAZHUGLNKCCGY-UHFFFAOYSA-N
Canonical SMILESCCN(CC)CCCC(C)NC1=C2C=C3C=C(C=CC3=NC2=CC(=C1)Cl)OC.Cl.Cl    
PubChem Compound IDCID 16760629.
SuperDrug ATC IDP01AX05
SuperDrug CAS ID000083896;
ClinicalTrials.govNCT00500812;
TargetRho-AInhibitor[1]
Ref 1Emerging drugs for spinal cord injury. Expert Opin Emerg Drugs. 2008 Mar;13(1):63-80. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543